Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
English
中文
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Search by expertise, name or affiliation
Additional file 1: of Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo
Jia Hong Chen
(Creator)
Wen Chien Huang
(Contributor)
Oluwaseun Adebayo Bamodu
(Contributor)
Peter M H Chang
(Creator)
Tsu-Yi Chao
(Contributor)
Tse Hung Huang
(Contributor)
Taipei Medical University Shuang Ho Hospital
TMU Research Center of Cancer Translational Medicine
International Master/Ph.D. Program in Medicine
Department of Internal Medicine
Graduate Institute of Clinical Medicine
Dataset
Overview
Research output
(1)
Research output
Research output per year
2019
2019
2019
1
Article
Research output per year
Research output per year
1 results
Publication Year, Title
(descending)
Publication Year, Title
(ascending)
Title
Type
Search results
2019
Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo
Chen, J. H., Huang, W. C., Bamodu, O. A., Chang, P. M. H.,
Chao, T. Y.
& Huang, T. H.,
Jun 27 2019
,
In:
BMC Cancer.
19
,
1
, 5811.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
Malignant Neoplasm
100%
Metastatic Breast Cancer
100%
Antibodies
100%
Monospecific Antibody
100%
Epithelial Mesenchymal Transition
100%
30
Citations (Scopus)